Showing results (211-220 of 928) with videos related to
Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|October 7, 2024
Continuous glucose monitoring-based metrics and the duration of hypoglycaemia events with once-weekly insulin icodec versus once-daily insulin glargine U100 in insulin-naive type 2 diabetes: an exploratory analysis of ONWARDS 1Richard M Bergenstal, Björg Ásbjörnsdóttir, Sara K Watt, et al.The Lancet. Diabetes & Endocrinology|September 9, 2024
Islet-after-kidney transplantation versus kidney alone in kidney transplant recipients with type 1 diabetes (KAIAK): a population-based target trial emulation in FranceMehdi Maanaoui, Rémi Lenain, Yohann Foucher, et al.The Lancet. Diabetes & Endocrinology|August 4, 2024
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort studyLeopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, et al.The Lancet. Diabetes & Endocrinology|August 4, 2024
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetesMuhammad Abdul-Ghani, Pietro Maffei, Ralph Anthony DeFronzoThe Lancet. Diabetes & Endocrinology|August 1, 2024
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trialBarbara M McGowan, Jens M Bruun, Matt Capehorn, et al.The Lancet. Diabetes & Endocrinology|July 22, 2024
Understanding the cause of type 2 diabetesRoy TaylorThe Lancet. Diabetes & Endocrinology|July 4, 2024
Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trialAllison Ross Eckard, Qian Wu, Abdus Sattar, et al.The Lancet. Diabetes & Endocrinology|July 11, 2024
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trialsEllen M Apperloo, Brendon L Neuen, Robert A Fletcher, et al.The Lancet. Diabetes & Endocrinology|August 19, 2024
Male hypogonadism: pathogenesis, diagnosis, and managementNipun Lakshitha De Silva, Nikoleta Papanikolaou, Mathis Grossmann, et al.The Lancet. Diabetes & Endocrinology|June 6, 2024
Associations between BMI and hospital resource use in patients hospitalised for COVID-19 in England: a community-based cohort studyJames Altunkaya, Carmen Piernas, Koen B Pouwels, et al.Pageof 93